The Board of Directors of HCA Healthcare, Inc. has authorized a buyback plan on January 27, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
323 USD | +1.28% |
|
+2.42% | +19.32% |
12/07 | Bernstein Adjusts Price Target on HCA Healthcare to $362 From $317 | MT |
09/07 | Barclays Adjusts HCA Healthcare's Price Target to $376 From $367, Keeps Overweight Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.32% | 8.35TCr | |
-21.99% | 7.54TCr | |
+2.32% | 2.67TCr | |
-5.06% | 1.82TCr | |
+6.95% | 1.81TCr | |
+7.69% | 1.65TCr | |
+76.20% | 1.41TCr | |
+76.56% | 1.3TCr | |
-27.89% | 1.27TCr | |
+20.55% | 1.23TCr |
- Stock Market
- Equities
- HCA Stock
- News HCA Healthcare, Inc.
- HCA Healthcare, Inc. authorizes a Buyback Plan.